Innate Pharma SA

Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021

23 Sep 2021 00:00:00 By Nasdaq GlobeNewswire

Monalizumab Data From COAST Trial Presented at ESMO Congress 2021

17 Sep 2021 06:45:00 By Nasdaq GlobeNewswire

Innate Pharma reports first half 2021 financial results and business update

15 Sep 2021 00:00:00 By Nasdaq GlobeNewswire

Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update

07 Sep 2021 00:00:00 By Nasdaq GlobeNewswire

Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress

02 Sep 2021 01:00:00 By Nasdaq GlobeNewswire

Innate Pharma to Participate in Upcoming Investor Conferences

30 Aug 2021 00:00:00 By Nasdaq GlobeNewswire

Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021

11 Aug 2021 00:00:00 By Nasdaq GlobeNewswire

NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021

12 Jul 2021 00:00:00 By Nasdaq GlobeNewswire

Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe Pneumonia

06 Jul 2021 00:00:00 By Nasdaq GlobeNewswire

Innate Pharma presents preliminary data from TELLOMAK trial showing clinical response for lacutamab in mycosis fungoides

22 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy

16 Jun 2021 00:00:00 By Nasdaq GlobeNewswire

Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021

14 Jun 2021 00:00:00 By Nasdaq GlobeNewswire

Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 2021 Annual Meeting

10 Jun 2021 00:00:00 By Nasdaq GlobeNewswire

New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma

09 Jun 2021 05:00:00 By Nasdaq GlobeNewswire

Outcome of Innate Pharma’s Annual General Meeting

28 May 2021 15:01:00 By Nasdaq GlobeNewswire

Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021

25 May 2021 00:00:00 By Nasdaq GlobeNewswire

Innate Pharma Virtual 2021 Annual General Meeting

12 May 2021 00:00:00 By Nasdaq GlobeNewswire

Innate Pharma First Quarter 2021 Report

11 May 2021 00:00:00 By Nasdaq GlobeNewswire

Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update

04 May 2021 00:00:00 By Nasdaq GlobeNewswire

Innate Pharma Files its 2020 Universal Registration Document (Document d'Enregistrement Universel) and 2020 Annual Report on Form 20-F

28 Apr 2021 00:00:00 By Nasdaq GlobeNewswire